| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Mr. Gregory O. MalcolmExec. VP & Controller | -2.30k | 203.41k | 売り | 88.44 | 22.20k | -9.39% |
| 2026-05-07 | Ms. Sally MasseyChief HR Officer | -8.60k | 751.63k | 売り | 87.41 | 21.94k | -28.16% |
| 2026-02-23 | Mr. John HazlinChief Growth Officer | -6.12k | 593.96k | Sale to Issuer | 97.10 | 29.87k | -17.00% |
| 2026-02-23 | Ms. Jennifer M. DanielsVice Chair | -12.35k | 1.20M | Sale to Issuer | 97.10 | 91.68k | -11.87% |
| 2026-02-23 | Mr. Stanley J. SutulaCFO | -19.75k | 1.92M | Sale to Issuer | 97.10 | 74.65k | -20.92% |
| 2026-02-23 | Mr. Gregory O. MalcolmExec. VP & Controller | -2.26k | 219.45k | Sale to Issuer | 97.10 | 24.45k | -8.46% |
| 2026-02-23 | Ms. Sally MasseyChief HR Officer | -8.21k | 796.80k | Sale to Issuer | 97.10 | 30.50k | -21.20% |
| 2026-02-23 | Mr. Panagiotis TsourapasCOO of Global Customer Dev., Europe Middle East Africa, Asia Pacific & Global Skin Health | -13.08k | 1.27M | Sale to Issuer | 97.10 | 88.44k | -12.89% |
| 2026-02-23 | Mr. Noel R. WallaceChairman, CEO & President | -68.25k | 6.63M | Sale to Issuer | 97.10 | 468.54k | -12.71% |
| 2026-02-11 | Mr. Panagiotis TsourapasCOO of Global Customer Dev., Europe Middle East Africa, Asia Pacific & Global Skin Health | -50.00k | 957.94k | Derivative Exercise and Sale | 76.41 - 97.81 | 75.73k | - |
| 2026-02-10 | Mr. John HazlinChief Growth Officer | -20.99k | 374.44k | Derivative Exercise and Sale | 76.41 - 94.25 | 23.10k | - |
| 2026-02-06 | Mr. Gregory O. MalcolmExec. VP & Controller | -12.75k | 235.82k | Derivative Exercise and Sale | 76.41 - 94.91 | 20.43k | - |
| 2026-02-05 | Ms. Sally MasseyChief HR Officer | -15.85k | 295.11k | Derivative Exercise and Sale | 76.41 - 95.03 | 21.86k | - |
| 2026-02-04 | Mr. Stanley J. SutulaCFO | -97.84k | 1.22M | Derivative Exercise and Sale | 81.78 - 94.27 | 55.64k | - |
| 2026-02-04 | Ms. Jennifer M. DanielsVice Chair | -22.00k | 485.02k | Derivative Exercise and Sale | 72.29 - 94.34 | 78.24k | - |
| 2026-02-04 | Mr. Noel R. WallaceChairman, CEO & President | -45.57k | 4.28M | 売り | 93.91 | 399.80k | -10.23% |
| 2025-12-03 | Mr. Stanley J. SutulaCFO | -385.00 | 30.11k | Sale to Issuer | 78.20 | 55.64k | -0.69% |
| 2025-12-03 | Mr. Noel R. WallaceChairman, CEO & President | -1.31k | 102.21k | Sale to Issuer | 78.20 | 445.01k | -0.29% |
| 2025-12-03 | Mr. Panagiotis TsourapasCOO of Global Customer Dev., Europe Middle East Africa, Asia Pacific & Global Skin Health | -221.00 | 17.28k | Sale to Issuer | 78.20 | 75.70k | -0.29% |
| 2025-12-03 | Mr. John HazlinChief Growth Officer | -156.00 | 12.20k | Sale to Issuer | 78.20 | 23.06k | -0.67% |
| 2025-12-03 | Mr. Gregory O. MalcolmExec. VP & Controller | -41.00 | 3.21k | Sale to Issuer | 78.20 | 20.38k | -0.20% |
| 2025-12-03 | Ms. Jennifer M. DanielsVice Chair | -213.00 | 16.66k | Sale to Issuer | 78.20 | 78.23k | -0.27% |
| 2025-11-21 | Ms. Sally MasseyChief HR Officer | -1.24k | 100.06k | 売り | 80.89 | 21.81k | -5.37% |
| 2025-09-12 | Ms. Jennifer M. DanielsVice Chair | -1.42k | 118.34k | Sale to Issuer | 83.28 | 78.37k | -1.78% |
| 2025-09-12 | Mr. Gregory O. MalcolmExec. VP & Controller | -241.00 | 20.07k | Sale to Issuer | 83.28 | 20.35k | -1.17% |
| 2025-09-12 | Mr. John HazlinChief Growth Officer | -826.00 | 68.79k | Sale to Issuer | 83.28 | 23.01k | -3.47% |
| 2025-09-12 | Mr. Panagiotis TsourapasCOO of Global Customer Dev., Europe Middle East Africa, Asia Pacific & Global Skin Health | -1.42k | 118.34k | Sale to Issuer | 83.28 | 75.83k | -1.84% |
| 2025-09-12 | Mr. Stanley J. SutulaCFO | -2.14k | 177.89k | Sale to Issuer | 83.28 | 55.92k | -3.68% |
| 2025-09-12 | Ms. Prabha Parameswaranインサイダー | -1.68k | 139.74k | Sale to Issuer | 83.28 | 63.78k | -2.56% |
| 2025-09-12 | Ms. Sally MasseyChief HR Officer | -1.12k | 92.94k | Sale to Issuer | 83.28 | 22.95k | -4.64% |
| 2025-09-12 | Mr. Noel R. WallaceChairman, CEO & President | -7.75k | 645.34k | Sale to Issuer | 83.28 | 445.61k | -1.71% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。